Interaction between IGF-IR and ER Induced by E2 and IGF-I

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Yu, Zhenghong ^a   Gao, Weimin ^b   Jiang, Enze ^c   Lu, Fang ^d   Zhang, Luo ^a   Shi, Zhaorong ^a   Wang, Xinxing ^a   Chen, Longbang ^a   Lv, Tangfeng ^a,b  

^a JINLING HOSPITAL   (China)

^b TEXAS TECH UNIVERSITY   (United States)

^c MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^d Nanjing Foreign Language School   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; COMPLEMENTARY DNA; ESTRADIOL; ESTRADIOL RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ARTICLE; BREAST CANCER; CANCER CELL; CELL GROWTH; CELL NUCLEUS; CELL PROLIFERATION; CELL STRAIN 3T3; CYTOPLASM; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PROTEIN PHOSPHORYLATION;

ANIMALS; CELL NUCLEUS; CELL PROLIFERATION; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; GREEN FLUORESCENT PROTEINS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INTRACELLULAR SPACE; MCF-7 CELLS; MICE; NIH 3T3 CELLS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, IGF TYPE 1; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 84877972255     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062642     Document Type: Article

References (28)

1. Contois LW, Nugent DP, Caron JM, Cretu A, Tweedie E, et al. (2010) Insulin-like growth factor binding protein-4 differentially inhibits growth factor-induced angiogenesis. J Biol Chem 287: 1779-89.
2. Baker SE, Lorenzen JA, Miller SW, Bunch TA, Jannuzi AL, et al. (2002) Genetic interaction between integrins and moleskin, a gene encoding a Drosophila homolog of importin-7. Genetics 162: 285-96.
3. Kawabe Y, Kuwayama H, Morio T, Urushihara H, Tanaka Y, (2002) A putative serpentine receptor gene tasA required for normal morphogenesis of primary stalk and branch structure in Polysphondylium pallidum. Gene 285: 291-9.
4. Stenoien DL, Mancini MG, Patel K, Allegretto EA, Smith CL, et al. (2000) Subnuclear trafficking of estrogen receptor-alpha and steroid receptor coactivator-1. Mol Endocrinol 14: 518-34.
5. Bartella V, De Marco P, Malaguarnera R, Belfiore A, Maggiolini M, (2012) New advances on the functional cross-talk between insulin-like growth factor-I and estrogen signaling in cancer. Cell Signal 24: 1515-21.
6. Fox EM, Miller TW, Balko JM, Kuba MG, Sánchez V, et al. (2011) A kinome-wide screen identifies the insulin/IGF-I receptor pathway as a mechanism of escape from hormone dependence in breast cancer. Cancer Res 71: 6773-84.
7. Zhu L, Pollard JW, (2007) Estradiol-17beta regulates mouse uterine epithelial cell proliferation through insulin-like growth factor 1 signaling. Proc Natl Acad Sci U S A. 104: 15847-51.
8. Kleinman D, Karas M, Roberts CT Jr, LeRoith D, Phillip M, et al. (1995) Modulation of insulin-like growth factor I (IGF-I) receptors and membrane-associated IGF-binding proteins in endometrial cancer cells by estradiol. Endocrinology 136: 2531-7.
9. Dufourny B, Alblas J, van Teeffelen HA, van Schaik FM, van der Burg B, et al. (1997) Mitogenic signaling of insulin-like growth factor I in MCF-7 human breast cancer cells requires phosphatidylinositol 3-kinase and is independent of mitogen-activated protein kinase. J Biol Chem 272: 31163-71.
10. Garcia-Segura LM, Arévalo MA, Azcoitia I, (2010) Interactions of estradiol and insulin-like growth factor-I signalling in the nervous system: new advances. Prog Brain Res 181: 251-72.
11. LeRoith D, (2000) Insulin-like growth factor I receptor signalling - overlapping or redundant pathways? Endocrinology 141: 1287-8.
12. Madhala-Levy D, Williams VC, Hughes SM, Reshef R, Halevy O, (2012) Cooperation between Shh and IGF-I in promoting myogenic proliferation and differentiation via the MAPK/ERK and PI3K/Akt pathways requires Smo activity. J Cell Physiol 227: 1455-64.
13. Hall JM, Chang CY, McDonnell DP, (2000) Development of peptide antagonists that target estrogen receptor beta-coactivator interactions. Mol Endocrinol 14: 2010-23.
14. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, et al. (2000) Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407: 538-41.
15. Casa AJ, Potter AS, Malik S, Lazard Z, Kuiatse I, et al. (2012) Estrogen and insulin-like growth factor-I (IGF-I) independently down-regulate critical repressors of breast cancer growth. Breast Cancer Res Treat 132: 61-73.
16. Hartog H, Horlings HM, van der Vegt B, Kreike B, Ajouaou A, et al. (2011) Divergent effects of insulin-like growth factor-1 receptor expression on prognosis of estrogen receptor positive versus triple negative invasive ductal breast carcinoma. Breast Cancer Res Treat 129: 725-36.
17. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, et al. (1995) Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270: 1491-4.
18. Castoria G, Migliaccio A, Bilancio A, Di Domenico M, de Falco A, et al. (2001) PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. EMBO J 20: 6050-9.
19. Joel PB, Smith J, Sturgill TW, Fisher TL, Blenis J, et al. (1998) pp90rsk1 regulates estrogen receptor-mediated transcription through phosphorylation of Ser-167. Mol Cell Biol 18: 1978-84.
20. Clark VP, Fannon S, Lai S, Benson R, (2001) Paradigm-dependent modulation of event-related fMRI activity evoked by the oddball task. Hum Brain Mapp 14: 116-27.
21. Feng W, Webb P, Nguyen P, Liu X, Li J, et al. (2001) Potentiation of estrogen receptor activation function 1 (AF-1) by Src/JNK through a serine 118-independent pathway. Mol Endocrinol 15: 32-45.
22. Kahlert S, Nuedling S, van Eickels M, Vetter H, Meyer R, et al. (2000) Estrogen receptor alpha rapidly activates the IGF-1 receptor pathway. J Biol Chem 275: 18447-53.
23. Stoll BA, (2002) Oestrogen/insulin-like growth factor-I receptor interaction in early breast cancer: clinical implications. Ann Oncol 13: 191-6.
24. Ahmad S, Singh N, Glazer RI, (1999) Role of AKT1 in 17beta-estradiol- and insulin-like growth factor I (IGF-I)-dependent proliferation and prevention of apoptosis in MCF-7 breast carcinoma cells. Biochem Pharmacol 58: 425-30.
25. Arnal JF, Bayard F, (2001) Vasculoprotective effects of oestrogens. Clin Exp Pharmacol Physiol 28: 1032-4.
26. Cardona-Gómez GP, Mendez P, DonCarlos LL, Azcoitia I, Garcia-Sequra LM, (2001) Interactions of estrogens and insulin-like growth factor-I in the brain: implications for neuroprotection. Brain Res Brain Res Rev 37: 320-34.
27. Fagan DH, Yee D, (2008) Crosstalk between IGF-1R and estrogen receptor signaling in breast cancer. J Mammary Gland Biol Neoplasia 13: 423-429.
28. Lisztwan J, Pornon A, Chen B, Chen S, Evans DB, (2008) The aromatase inhibitor letrozole and inhibitors of insulin-like growth factor I receptor synergistically induce apoptosis in in vitro models of estrogen-dependent breast cancer. Breast Cancer Res 10: R56.